JP2018515550A5 - - Google Patents

Download PDF

Info

Publication number
JP2018515550A5
JP2018515550A5 JP2017560135A JP2017560135A JP2018515550A5 JP 2018515550 A5 JP2018515550 A5 JP 2018515550A5 JP 2017560135 A JP2017560135 A JP 2017560135A JP 2017560135 A JP2017560135 A JP 2017560135A JP 2018515550 A5 JP2018515550 A5 JP 2018515550A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrazinocarbonyl
pyridin
chloro
methylbenzoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017560135A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018515550A (ja
JP6689887B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2016/050142 external-priority patent/WO2016185490A1/en
Publication of JP2018515550A publication Critical patent/JP2018515550A/ja
Publication of JP2018515550A5 publication Critical patent/JP2018515550A5/ja
Application granted granted Critical
Publication of JP6689887B2 publication Critical patent/JP6689887B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017560135A 2015-05-18 2016-05-18 新規アミドヘテロアリールアロイルヒドラジドエチン Expired - Fee Related JP6689887B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1953MU2015 2015-05-18
IN1953/MUM/2015 2015-05-18
PCT/IN2016/050142 WO2016185490A1 (en) 2015-05-18 2016-05-18 Novel amidoheteroaryl aroyl hydrazide ethynes

Publications (3)

Publication Number Publication Date
JP2018515550A JP2018515550A (ja) 2018-06-14
JP2018515550A5 true JP2018515550A5 (enExample) 2019-05-09
JP6689887B2 JP6689887B2 (ja) 2020-04-28

Family

ID=57319598

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017560135A Expired - Fee Related JP6689887B2 (ja) 2015-05-18 2016-05-18 新規アミドヘテロアリールアロイルヒドラジドエチン

Country Status (13)

Country Link
US (1) US10150733B2 (enExample)
EP (1) EP3297991B1 (enExample)
JP (1) JP6689887B2 (enExample)
KR (1) KR20180011772A (enExample)
CN (1) CN107709300A (enExample)
AU (1) AU2016263311A1 (enExample)
BR (1) BR112017024633A2 (enExample)
CA (1) CA2985161A1 (enExample)
EA (1) EA032697B1 (enExample)
ES (1) ES2774501T3 (enExample)
MX (1) MX2017014752A (enExample)
WO (1) WO2016185490A1 (enExample)
ZA (1) ZA201707664B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA037697B1 (ru) * 2016-06-02 2021-05-12 Сан Фарма Адвансед Ресёрч Компани Лимитед Лечение болезни паркинсона
WO2017208267A1 (en) 2016-06-02 2017-12-07 Sun Pharma Advanced Research Company Limited Treatment for parkinson's disease
MA47798A (fr) 2017-03-15 2020-01-22 Sun Pharma Advanced Res Co Ltd Nouvelle dispersion amorphe d'acide cyclopropanecarboxylique (5-{5-[ n'-(2-chloro-6-méthylbenzoyl) hydrazinocarbonyl] -2-méthyl-phényléthynyl}-pyridin-2-yl) amide
CN120305263A (zh) 2018-06-15 2025-07-15 汉达癌症医药责任有限公司 卡博替尼的盐类于制备治疗癌症的剂型的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007133560A2 (en) 2006-05-08 2007-11-22 Ariad Pharmaceuticals, Inc. Acetylenic heteroaryl compounds
CN103370324B (zh) * 2010-12-27 2016-05-18 孙树萍 作为蛋白激酶抑制剂的芳炔类衍生物及其医疗用途
AU2012208388C1 (en) * 2011-01-21 2017-04-27 Sun Pharma Advanced Research Company Ltd Diarylacetylene hydrazide containing tyrosine kinase inhibitors
US8859541B2 (en) 2012-02-27 2014-10-14 Boehringer Ingelheim International Gmbh 6-alkynylpyridines

Similar Documents

Publication Publication Date Title
CA2774133C (en) Compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same
JP2008505117A5 (enExample)
JP2023103414A (ja) [(5-(ハロフェニル)-3-ヒドロキシピリジン-2-カルボニル)-アミノ]アルカン酸誘導体の調製における中間体としての5-((ハロフェニル)-3-ハロ-ピリジン-2-イル)-ニトリル誘導体
TWI344955B (en) Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient
ES2281565T3 (es) Inhibidores de la integrasa de vih de tipo dihidroxipirimidina carboxamida.
JP2006524222A5 (enExample)
JP2011525192A5 (enExample)
JP2007502843A5 (enExample)
JP2013542994A5 (enExample)
JP2025510074A5 (enExample)
JP2009515988A5 (enExample)
JP2012510502A5 (enExample)
JP2006510737A (ja) ニコチンアミド系キナーゼ阻害薬
JP2010535722A5 (enExample)
JP2009534358A5 (enExample)
JP2006502119A5 (enExample)
JP2007524707A5 (enExample)
FR2943669A1 (fr) Derives de nicotinamide,leur preparation et leur application en therapeutique
WO2007136640A2 (en) Processes for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
JP2016500653A5 (enExample)
JP2013544854A5 (enExample)
JP2006523698A5 (enExample)
JP2010522214A5 (enExample)
EP1569907A1 (en) Nicotinamide-based kinase inhibitors
RU2006130686A (ru) Новые пиперидины в качестве модуляторов хемокинов (ccr)